PLM-102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLM-102, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia [Phase 1]